Transcriptomics and Metabolomics Identify Drug Resistance of Dormant Cell in Colorectal Cancer
Background: Tumor dormancy is an important way to develop drug resistance. This study aimed to identify the characteristics of colorectal cancer (CRC) cell dormancy.Methods: Based on the CRC cohorts, a total of 1,044 CRC patients were included in this study, and divided into a dormant subgroup and p...
Saved in:
Main Authors: | Lang Xie (Author), Renli Huang (Author), Hongyun Huang (Author), Xiaoxia Liu (Author), Jinlong Yu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
La belle (au bois) dormant
by: López Mozo, Jerónimo
Published: (2018) -
White lesion: A dormant malignancy?
by: Vela D Desai, et al.
Published: (2014) -
Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism Underlying Tadalafil in Colorectal Cancer
by: Pan Zhao, et al.
Published: (2022) -
Dormant Account Reactivation at Al-Shajar Capital
by: Muhammad Yawar Uz Zaman, et al.
Published: (2019) -
Activating dormant strongyloidiasis secondary to COVID-19 treatment
by: Fahad Alkaabba, et al.
Published: (2022)